St. Jude Medical’s Q1 beats own guidance and Wall Street’s

By Brad Perriello

St. Jude Medical’s 1st-quarter earnings top both its own guidance and Wall Street’s outlook, prompting the medical device company to boost its 2015 sales forecast.

First-quarter results for St. Jude Medical (NYSE:STJ) beat both its own forecast and Wall Street’s today, prompting the medical device company to raise its sales outlook for the rest of the year.

St. Paul, Minn.-based St. Jude reported profits of $262 million, or 91¢ per share, on sales of $1.35 billion for the 3 months ended April 4.

Although that’s a -1.3% top-line slide compared with Q1 2014, the bottom line grew 5.2%. And adjusted to exclude 1-time items, earnings per share were 93¢, 2¢ ahead of The Street and St. Jude.

READ MORE HERE

Add a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Keep Up to Date with the Most Important News

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use